Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech award win

BiDaKidney Wins James Dyson Award Philippines

Analysis based on 6 articles · First reported Sep 16, 2026 · Last updated Sep 21, 2026

Sentiment
5
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The event has negligible direct impact on public equity or credit markets, as BiDaKidney is a student-developed device still in development and not yet a commercial product. It carries mild positive sentiment for the medical device and home healthcare sectors, highlighting demand for affordable home dialysis solutions in emerging markets.

medical devices healthcare

University of the Philippines Diliman graduates Andrew Jacob Buensalido and Allyson Cabrestante were named Philippine national winners of the James Dyson Award 2026 for BiDaKidney, a low-cost, semi-automated peritoneal dialysis machine designed to make home-based treatment simpler, safer, and more accessible. The award is run by the Jamestown Foundation, the engineering-education charity of inventor Sir James Dyson, and is now in its 21st year, operating across 28 countries and regions. BiDaKidney automates key steps in managing dialysis fluid using a controlled pump and built-in weight sensors, working with standard peritoneal dialysis supplies to reduce manual work, contamination risks, and record-keeping burden for patients and caregivers. The team received PHP398,280 as the national prize to support further development and commercialization, and plans to refine usability and safety features, explore battery-powered operation for power interruptions, and prepare for formal clinical testing. The award comes amid growing dialysis demand in the Philippines, where the number of people undergoing dialysis reached 64,845 in 2024, up 22 percent from 53,296 in 2023, according to figures cited by the James Dyson Award. Philippine national runners-up Sentinel, a concrete structural-damage sensor, and OrthoFlex, a robot-assisted elbow rehabilitation device, will advance alongside BiDaKidney to the international stage. Dyson engineers will select an international Top 20 shortlist announced on October 14, with global winners announced on November 4.

70 Jamestown Foundation awarded national prize Andrew Jacob Buensalido
70 Jamestown Foundation awarded national prize Allyson Cabrestante
50 Andrew Jacob Buensalido developed BiDaKidney
50 Allyson Cabrestante developed BiDaKidney
40 Andrew Jacob Buensalido advanced to international stage Jamestown Foundation
40 Allyson Cabrestante advanced to international stage Jamestown Foundation
per
Co-developer of BiDaKidney and Philippine national winner, receiving prize money to further develop and commercialize the device.
Importance 90.0 Sentiment 15.0
per
Co-developer of BiDaKidney and Philippine national winner, receiving prize money to further develop and commercialize the device.
Importance 90.0 Sentiment 15.0
ngo
The foundation runs the award and granted the PHP398,280 national prize, advancing its mission of supporting young inventors.
Importance 60.0 Sentiment 5.0
per
Sir James Dyson's award program and foundation gain visibility through the recognition of BiDaKidney, reinforcing the award's profile.
Importance 40.0 Sentiment 5.0
cnt
The country benefits from recognition of local innovation addressing its growing dialysis burden, with 64,845 patients in 2024.
Importance 35.0 Sentiment 3.0
priv
Dyson engineers will judge the international stage, linking the company to healthcare innovation without direct financial effect.
Importance 30.0 Sentiment 3.0
per
As a national judge, he endorsed BiDaKidney as an example of engineering addressing real healthcare challenges.
Importance 20.0 Sentiment 2.0
per
As a national judge, he praised the team's disciplined problem-solving approach in developing BiDaKidney.
Importance 20.0 Sentiment 2.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.